Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengting Qin

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Elife|July 26, 2024
RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemiaXiaozhuo Yu, Wen Zhou, Xiaodong Chen, et al.
In Vitro Cellular & Developmental Biology. Animal|February 10, 2017
Apigenin attenuates streptozotocin-induced pancreatic β cell damage by its protective effects on cellular antioxidant defenseNing Wang, Wen Jing Yi, Lu Tan, et al.
Oncology Reports|January 8, 2021
Involvement of Blnk and Foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cellsPing Zhang, Yang Wang, Mengting Qin, et al.
Oncoimmunology|May 5, 2020
CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse modelsZhuangwei Lv, Ping Zhang, Dandan Li, et al.
Cancer Science|May 5, 2021
RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivoMeng Yuan, Yang Wang, Mengting Qin, et al.
Frontiers in Neuroscience|August 28, 2023
Decreased GABA levels of the anterior and posterior cingulate cortex are associated with executive dysfunction in mild cognitive impairmentXiaona Fu, Mengting Qin, Xiaoming Liu, et al.
Theranostics|March 17, 2025
CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignanciesMengting Qin, Juan Ren, Xiaodong Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 4, 2024
A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasisHaroon Iqbal, Anam Razzaq, Fan Liu, et al.
Journal of Medicinal Chemistry|December 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In VivoYuqi Jiang, Jie Xu, Kairui Yue, et al.
Blood Advances|July 11, 2022
Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AIDPing Zhang, Mengting Qin, Yang Wang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Elife|July 26, 2024
RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemiaXiaozhuo Yu, Wen Zhou, Xiaodong Chen, et al.
In Vitro Cellular & Developmental Biology. Animal|February 10, 2017
Apigenin attenuates streptozotocin-induced pancreatic β cell damage by its protective effects on cellular antioxidant defenseNing Wang, Wen Jing Yi, Lu Tan, et al.
Oncology Reports|January 8, 2021
Involvement of Blnk and Foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cellsPing Zhang, Yang Wang, Mengting Qin, et al.
Oncoimmunology|May 5, 2020
CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse modelsZhuangwei Lv, Ping Zhang, Dandan Li, et al.
Cancer Science|May 5, 2021
RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivoMeng Yuan, Yang Wang, Mengting Qin, et al.
Frontiers in Neuroscience|August 28, 2023
Decreased GABA levels of the anterior and posterior cingulate cortex are associated with executive dysfunction in mild cognitive impairmentXiaona Fu, Mengting Qin, Xiaoming Liu, et al.
Theranostics|March 17, 2025
CD19-targeted HSP90 inhibitor nanoparticle combined with TKIs reduces tumor burden and enhances T-cell immunity in murine B-cell malignanciesMengting Qin, Juan Ren, Xiaodong Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 4, 2024
A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasisHaroon Iqbal, Anam Razzaq, Fan Liu, et al.
Journal of Medicinal Chemistry|December 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In VivoYuqi Jiang, Jie Xu, Kairui Yue, et al.
Blood Advances|July 11, 2022
Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AIDPing Zhang, Mengting Qin, Yang Wang, et al.
Pageof 4